呂欣穎(Lu, Hsin-Ying) 助理教授

Email
hsinyinglu110@tmu.edu.tw
現   職
外科學科 助理教授

學經歷

學 歷

畢業學校與學位[修業時間]
國立陽明交通大學臨床醫學研究所 博士
2011/09~2016/08
中國醫藥大學復健科學所 碩士
2009/09~2011/07
義守大學物理治療學系 學士
2002/09~2006/07

本校學術經歷

任職單位與職稱[起迄時間]
外科學科助理教授
2022/05/10~

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
無資料!

其它經歷

任職單位與職稱[起迄時間]
萬芳醫院醫學研究員
國立陽明大學博士級研究員
2017/01/01~2019/07/31
臺北榮民總醫院博士級研究員
2016/09/01~2016/12/31
北醫附設醫院物理治療師
2007/08/17~2009/07/31

專長與研究領域

學門領域
學術專長

論文著作

清冊下載


1. 2025 Aspalathin-rich unfermented Aspalathus linearsis extract mitigates vascular endothelial inflammation by inhibiting the TNF-α/Hexokinase 2/NF-κB signaling pathway . Journal of Agriculture and Food Research .2025

2. 2024 Hsin-Ying Lu, Fwu-Long Mi, Chih-Ming Chou,Chi Lin,Yi-Yu Chen,Cheng-Ying Chu7,8, Cheng-Yang Liu, Yu-Lin Amy Lee, Chun Che Shih, and Chia-Hsiung Cheng. Layer-by-layer assembly of quercetin-loaded zein/γPGA/low-molecular-weight chitosan/fucoidan nanosystem for targeting inflamed blood vessels . International Journal of Biological Macromolecules .2024

3. 2024 Kuo LK,Fu YK, Yeh CC, Lee CY,Chung CJ,Shih LJ, Lu HY and Chuu CP. Combined Treatment of Caffeic Acid Phenethyl Ester With Docetaxel Inhibits Survival of Non-small-cell Lung Cancer Cells via Suppression of c-MYC. . Anticancer Res. .2024 ;(44):4915-4928

4. 2022 Hsu HL,Huang CY,Lu HY,Hsu CP, Chen PL,Chen IM , Shih CC. Aortic remodeling of the provisional extension to induce complete attachment technique in DeBakey type IIIb aortic dissection. . J Formos Med Assoc. .2022

5. 2022 Wu TC,Chang WH,Lu HY,Shih CC. Tolvaptan reduces angiotensin II-induced experimental abdominal aortic aneurysm and dissection. . Vascul Pharmacol. .2022

6. 2021 Lu HY,Hsu HL,Li CH,Li SJ,Lin SJ,Shih CM, Shih CC. Hydrogen Sulfide Attenuates Aortic Remodeling in Aortic Dissection Associating with Moderated Inflammation and Oxidative Stress through a NO-Dependent Pathway. . Antioxidants (Basel) .2021

7. 2021 Lu HY,Shih CM,Sung SH,Wu ATH,Cheng TM,Lin YC, Shih CC. Galectin-3 as a Biomarker for Stratifying Abdominal Aorti.84 c Aneurysm Size in a Taiwanese Population. . Front Cardiovasc Med. .2021

8. 2021 Chang LH,Chuang EY,Cheng TM,Lin C,Shih CM,Wu AT,heng PR, Lu HY, Shih CC, Mi FL. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent. . Acta Biomater. .2021

9. 2021 Ho JY,Lu HY,Cheng HH,Kuo YC,Lee YA ,Cheng CH. UBE2S activates NF-kappaB signaling by binding with IkappaBalpha and promotes metastasis of lung adenocarcinoma cells. . Cell Oncol (Dordr) .2021

10. 2020 Huang CY,Chen PL,Lu HY,Hsu HL,Kuo TT,Chen IM, Hsu CP, Shih CC. Midterm result of custom-made iliac branch device for common iliac aneurysm with and without abdominal aortic aneurysm. . Interact Cardiovasc Thorac Surg. .2020

11. 2020 Lu HY,Shih CM,Huang CY,Wu ATH,Cheng TM,Mi FL, Shih CC. Galectin-3 Modulates Macrophage Activation and Contributes Smooth Muscle Cells Apoptosis in Abdominal Aortic Aneurysm Pathogenesis. . Int J Mol Sci. .2020

12. 2016 Lu HY,Huang CY,Shih CM,Lin YW,Tsai CS,Lin FY, Shih CC. A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms. . J Vasc Surg. .2016

13. 2015 Lu HY,Huang CY,Shih CM,Chang WH,Tsai CS,Lin FY, Shih CC. Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice. . PLoS One .2015

研究計畫

計畫名稱
113 鐵凋亡抑制劑調控巨噬細胞極化誘發外泌體小分子核核糖核酸-let7表現改善主動脈剝離發生(2/3)
補助單位
國家科學及技術委員會

計畫名稱
112 鐵凋亡抑制劑調控巨噬細胞極化誘發外泌體小分子核核糖核酸-let7表現改善主動脈剝離發生(1/3)
補助單位
國家科學及技術委員會

計畫名稱
111 半乳糖凝集素-3透過與類鐸受體4的相互作用引發巨噬細胞焦亡促進發炎驅動主動脈剝離發生
補助單位
國家科學及技術委員會

計畫名稱
110 硫化氫治療主動脈剝離療效透過調控Nrf2-GPX4訊息路徑抑制細胞鐵凋亡之研究
補助單位
科技部